+1 628 258 0071(US) +44
2035 002 764(UK)
Search For Reports
GET FREE SAMPLE R
Home / Reports / Healthcare
/ Cardiac Resynchronization Therapy
Global Cardiac Resynchronization Therapy (CRT) Market is expected to cross USD 4.7 Million by 2025 at a CAGR of 5.5%.
The increasing prevalence rate of cardiac diseases followed by, rising demand for invasive techniques, fueling
market growth. Cardiac disease is the leading cause of death for US population. In 2018, it was estimated that
2,300 people died in America per day due to cardiovascular diseases. Also, around 92.1 million American adult
population are living with some form of cardiac disease or the aftereffects of the stroke.
Cardiac diseases are most common in low- and middle-income countries and these disorders.
Cardiac Resynchronization Therapy (CRT) Market Influencer
Increasing awareness of cardiac resynchronization therapy (CRT) devices and favorable government regulation
towards reimbursement scenario.
Cardiac Resynchronization Therapy (CRT) Market Drivers
Increasing sedentary lifestyle – leading a sedentary lifestyle is a major public health issue, it is
increasingly spreading in many nations irrespective of being linked to various type of chronic health
Rising geriatric population
Rising investments in the healthcare sector – In 2016, the expenditure of US on medical and health
research and development (R&D) was around USD 171.8 billion, and US healthcare expenditure was USD
Increasing technologically advances in medical devices
The rising number of surgical procedures
The growing number of intensive care units
Cardiac Resynchronization Therapy (CRT) Market Restraints
The high cost of therapy – In 2017, the initial cost of cardiac resynchronization therapy pacemaker
(CRT-P) is USD 16,218.44 and USD 36,263.73 of cardiac resynchronization therapy defibrillator (CRT-D).
Cardiac Resynchronization Therapy (CRT) Market eg